This study is looking at the symptoms experienced by patients who have surgery for gastric (stomach) or gastroesophageal junction (where the esophagus meets the stomach) cancer. Researchers want to compare symptoms between two types of minimally invasive surgery: proximal gastrectomy (MIPG) and total gastrectomy (MITG). You might be able to join if you are at least 18 years old, have been diagnosed with non-metastatic gastric or GEJ adenocarcinoma, and are scheduled for either MIPG or MITG surgery. The study aims to see if MIPG leads to better appetite after surgery compared to MITG. You would complete questionnaires before and after your surgery to share your experiences. The study is currently unclear on its recruitment status.

Study design

This is an observational study comparing two types of minimally invasive surgery for gastric and gastroesophageal junction cancers. It plans to include 20 participants.

What's involved

You would complete a questionnaire within 30 days before your surgery and then again at 1, 3, 6, and 12 months after surgery.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 12 months after surgery, with symptom questionnaires collected at various time points.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.